Latest available resultsQuarter ended March 31, 202610-Q · April 29, 2026
Filed with the SECHUMANA INC
HUMHealthcare
Results announcedJuly 29, 2026▲ +4.3%
Detailed filing pendingNext reportNovember 6, 2026pre-market · Analyst forecast -1.008 $/share
Revenue
$39.65B
▲ +23.5% vs prior year% YoY
Net income
$1.19B
▼ -4.7% vs prior year% YoY
EPS
9.83$
▼ -4.6% vs prior year% YoY
Net margin
3.0%
▼ -0.9 percentage points vs prior year pp YoY
Revenue▲ +23.5 %
Margins (% of revenue)Gross N/AOperatingNet
Net income▼ -4.7 %
EPS▼ -4.6 %
View financial tableQuarter ended March 31, 2026
| Metric | Value | Context |
|---|---|---|
| Operations | ||
| Revenue | $39.65B | |
| Gross profit | — | never filed |
| Operating income | $1.75B | 4.4 % |
| Net income | $1.19B | 3.0 % |
| R&D | — | never filed |
| EPS (diluted) | 9.83 $ | |
| Balance sheet | ||
| Assets | $55.28B | |
| Liabilities | $36.63B | |
| Equity | $18.65B | |
| Cash | $4.95B | |
| Capital | ||
| Shares outstanding | 120.06M | as of 2026-03-31 |
| Public float | — | |